About
Aitia develops a Gemini Digital Twin platform that leverages causal AI and multiomic clinical data to create in silico models of human disease biology, helping pharmaceutical companies discover and develop new drugs.
Explore Aitia's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.